The kynurenine pathway is involved in bacterial meningitis

Journal of Neuroinflammation

Lucymara F Agnez-Lima²  Stephen L Leib¹  Denis Grandgirard¹  Fladjule Rejane Soares de Souza²  Fabrícia Lima Fontes²  Caroline L Bellac¹  Stephan Christen¹  Leonam G Coutinho² 

[1] Institute for Infectious Diseases, University of Bern, Friedbühlstrasse 51, Bern, CH-3010, Switzerland;Departamento de Biologia Celular e Genética, Universidade Federal do Rio Grande do Norte, UFRN, Campus Universitário, Lagoa Nova, Natal, RN, Brazil

关键词: AADAT?+?401C/T;    Cytokines;    CSF;    IDO activity;    Kynurenine;    Bacterial meningitis;   

Others  :  1150721
DOI  :  10.1186/s12974-014-0169-4

 received in 2014-07-15, accepted in 2014-09-17,  发布年份 2014

【 摘 要 】

Background

Bacterial meningitis (BM) is characterized by an intense host inflammatory reaction, which contributes to the development of brain damage and neuronal sequelae. Activation of the kynurenine (KYN) pathway (KP) has been reported in various neurological diseases as a consequence of inflammation. Previously, the KP was shown to be activated in animal models of BM, and the association of the SNP AADAT?+?401C/T (kynurenine aminotransferase II - KAT II) with the host immune response to BM has been described. The aim of this study was to investigate the involvement of the KP during BM in humans by assessing the concentrations of KYN metabolites in the cerebrospinal fluid (CSF) of BM patients and their relationship with the inflammatory response compared to aseptic meningitis (AM) and non-meningitis (NM) groups.

Methods

The concentrations of tryptophan (TRP), KYN, kynurenic acid (KYNA) and anthranilic acid (AA) were assessed by HPLC from CSF samples of patients hospitalized in the Giselda Trigueiro Hospital in Natal (Rio Grande do Norte, Brazil). The KYN/TRP ratio was used as an index of indoleamine 2,3-dioxygenase (IDO) activity, and cytokines were measured using a multiplex cytokine assay. The KYNA level was also analyzed in relation to AADAT?+?401C/T genotypes.

Results

In CSF from patients with BM, elevated levels of KYN, KYNA, AA, IDO activity and cytokines were observed. The cytokines INF-? and IL-1Ra showed a positive correlation with IDO activity, and TNF-? and IL-10 were positively correlated with KYN and KYNA, respectively. Furthermore, the highest levels of KYNA were associated with the AADAT?+?401 C/T variant allele.

Conclusion

This study suggests a downward modulatory effect of the KP on CSF inflammation during BM.

【 授权许可】

   
2014 Coutinho et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C, Mohammedi I, Renard B, Mourvillier B, Bruneel F, Ricard JD, Timsit JF: Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med 2006, 34:2758-2765.
• [2]Bedford H: Prevention, treatment and outcomes of bacterial meningitis in childhood. Prof Nurse 2001, 17:100-102.
• [3]Lepage P, Dan B: Infantile and childhood bacterial meningitis. Handb Clin Neurol 2013, 112:1115-1125.
• [4]Neal JW, Gasque P: How does the brain limit the severity of inflammation and tissue injury during bacterial meningitis? J Neuropathol Exp Neurol 2013, 72:370-385.
• [5]Bellac CL, Coimbra RS, Christen S, Leib SL: Pneumococcal meningitis causes accumulation of neurotoxic kynurenine metabolites in brain regions prone to injury. Neurobiol Dis 2006, 24:395-402.
• [6]Bellac CL, Coimbra RS, Christen S, Leib SL: Inhibition of the kynurenine-NAD?+?pathway leads to energy failure and exacerbates apoptosis in pneumococcal meningitis. J Neuropathol Exp Neurol 2010, 69:1096-1104.
• [7]Fatokun AA, Hunt NH, Ball HJ: Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease. Amino Acids 2013, 45:1319-1329.
• [8]Mándi Y, Vécsei L: The kynurenine system and immunoregulation. J Neural Transm 2012, 119:197-209.
• [9]Campbell BM, Charych E, Lee AW, Möller T: Kynurenines in CNS disease: regulation by inflammatory cytokines. Front Neurosci 2014, 8:12.
• [10]Reyes Ocampo J, Lugo Huitrón R, González-Esquivel D, Ugalde-Muñiz P, Jiménez-Anguiano A, Pineda B, Pedraza-Chaverri J, Ríos C, Pérez de la Cruz V: Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxid Med Cell Longev 2014, 2014:646909.
• [11]Leib SL, Kim YS, Ferriero DM, Tauber MG: Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J Infect Dis 1996, 173:166-171.
• [12]Guillemin GJ, Smith DG, Smythe GA, Armati PJ, Brew BJ: Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 2003, 527:105-512.
• [13]Guillemin GJ, Smythe G, Takikawa O, Brew BJ: Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 2005, 49:15-23.
• [14]Braidy N, Grant R, Adams S, Brew BJ, Guillemin GJ: Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox Res 2009, 16:77-86.
• [15]Manéglier B, Malleret B, Guillemin GJ, Spreux-Varoquaux O, Devillier P, Rogez-Kreuz C, Porcheray F, Thérond P, Dormont D, Clayette P: Modulation of indoleamine-2,3-dioxygenase expression and activity by HIV-1 in human macrophages. Fundam Clin Pharmacol 2009, 23:573-581.
• [16]Koedel U, Winkler F, Angele B, Fontana A, Pfister HW: Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 2002, 22:39-49.
• [17]Puccetti P, Grohmann U: IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 2007, 7:817-823.
• [18]Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L: Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 2006, 281:22021-22028.
• [19]Hsieh YC, Chen RF, Yeh YS, Lin MT, Hsieh JH, Chen SH: Kynurenic acid attenuates multiorgan dysfunction in rats after heatstroke. Acta Pharmacol Sin 2011, 32:167-174.
• [20]de Souza FR, Fontes FL, da Silva TA, Coutinho LG, Leib SL, Agnez-Lima LF: Association of kynurenine aminotransferase II gene C401T polymorphism with immune response in patients with meningitis. BMC Med Genet 2011, 12:51. BioMed Central Full Text
• [21]Mucke L, Eddleston M: Astrocytes in infectious and immune-mediated diseases of the central nervous system. Faseb J 1993, 7:1226-1232.
• [22]Schroten H, Spors B, Hucke C, Stins M, Kim KS, Adam R, Däubener W: Potential role of human brain microvascular endothelial cells in the pathogenesis of brain abscess: inhibition of Staphylococcus aureus by activation of indoleamine 2,3-dioxygenase. Neuropediatrics 2001, 32:206-210.
• [23]Adam R, Rüssing D, Adams O, Ailyati A, Sik Kim K, Schroten H, Däubener W: Role of human brain microvascular endothelial cells during central nervous system infection. Significance of indoleamine 2,3-dioxygenase in antimicrobial defence and immunoregulation. Thromb Haemost 2005, 94:341-346.
• [24]Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A, Larsen SA, Lee K, Leonard HL, Markey SP, Martin A, Milstein S, Mouradian MM, Pranzatelli MR, Quearry BJ, Salazar A, Smith M, Strauss SE, Sunderland T, Swedo SW, Tourtellotte WW: Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992, 115:1249-1273.
• [25]Hiraku Y, Inoue S, Oikawa S, Yamamoto K, Tada S, Nishino K, Kawanishi S: Metal-mediated oxidative damage to cellular and isolated DNA by certain tryptophan metabolites. Carcinogenesis 1995, 16:349-356.
• [26]Goldstein LE, Leopold MC, Huang X, Atwood CS, Saunders AJ, Hartshorn M, Lim JT, Faget KY, Muffat JA, Scarpa RC, Chylack LT Jr, Bowden EF, Tanzi RE, Bush AI: 3-hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry 2000, 39:7266-7275.
• [27]Christen S, Peterhans E, Stocker R: Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc Natl Acad Sci U S A 1990, 87:2506-2510.
• [28]Leipnitz G, Schumacher C, Dalcin KB, Scussiato K, Solano A, Funchal C, Dutra-Filho CS, Wyse AT, Wannmacher CM, Latini A, Wajner M: In vitro evidence for an antioxidant role of 3-hydroxykynurenine and 3-hydroxyanthranilic acid in the brain. Neurochem Int 2007, 50:83-94.
• [29]Thomas SR, Stocker R: Antioxidant activities and redox regulation of interferon-gamma-induced tryptophan metabolism in human monocytes and macrophages. Adv Exp Med Biol 1999, 467:541-552.
• [30]Grant R, Kapoor V: Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels. Biochem Pharmacol 2003, 66:1033-1036.
• [31]Wennekamp J, Henneke P: Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev 2008, 225:114-127.
• [32]Kornelisse RF, Hack CE, Savelkoul HF, van der Pouw Kraan TC, Hop WC, van Mierlo G, Suur MH, Neijens HJ, de Groot R: Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. Infect Immun 1997, 65:877-881.
• [33]Glimaker M, Olcén P, Andersson B: Interferon-gamma in cerebrospinal fluid from patients with viral and bacterial meningitis. Scand J Infec Dis 1994, 26:141-147.
• [34]Mitchell AJ, Yau B, McQuillan JA, Ball HJ, Too LK, Abtin A, Hertzog P, Leib SL, Jones CA, Gerega SK, Weninger W, Hunt NH: Inflammasome-dependent IFN-? drives pathogenesis in Streptococcus pneumoniae meningitis. J Immunol 2012, 189:4970-4980.
• [35]Too LK, Ball HJ, McGregor IS, Hunt NH: The pro-inflammatory cytokine interferon-gamma is an important driver of neuropathology and behavioural sequelae in experimental pneumococcal meningitis. Brain Behav Immun 2014, 40:252-268.
• [36]Too LK, McQuillan JA, Ball HJ, Kanai M, Nakamura T, Funakoshi H, McGregor IS, Hunt NH: The kynurenine pathway contributes to long-term neuropsychological changes in experimental pneumococcal meningitis. Behav Brain Res 2014, 270:179-195.
• [37]Kralovicova J, Vorechovsky I: Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition. Nucleic Acids Res 2007, 35:6399-6413.
• [38]Hunt NH, Golenser J, Chan-Ling T, Parekh S, Rae C, Potter S, Medana IM, Miu J, Ball HJ: Immunopathogenesis of cerebral malaria. Int J Parasitol 2006, 36:569-582.
• [39]Hucke C, MacKenzie CR, Adjogble KD, Takikawa O, Daubener W: Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2,3-dioxygenase. Infect Immun 2004, 72:2723-2730.
• [40]Entrena A, Camacho ME, Carrión MD, López-Cara LC, Velasco G, León J, Escames G, Acuña-Castroviejo D, Tapias V, Gallo MA, Vivó A, Espinosa A: Kynurenamines as neural nitric oxide synthase inhibitors. J Med Chem 2005, 48:8174-8181.
• [41]Samelson-Jones BJ, Yeh SR: Interactions between nitric oxide and indoleamine 2,3-dioxygenase. Biochemistry 2006, 45:8527-8538.
• [42]Wang Y, Liu H, McKenzie G, Witting PK, Stasch JP, Hahn M, Changsirivathanathamrong D, Wu BJ, Ball HJ, Thomas SR, Kapoor V, Celermajer DS, Mellor AL, Keaney JF Jr, Hunt NH, Stocker R: Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med 2010, 16:279-285.